Rockefeller Capital Management
UTHR icon

Rockefeller Capital Management’s United Therapeutics UTHR Stock Holding History

Rockefeller Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$816K Sell
1,506
-56
-4% -$31.5K ﹤0.01% 1832
2026
Q1 		$926K Buy
1,562
+239
+18% +$119K ﹤0.01% 1645
2025
Q4 		$645K Buy
1,323
+127
+11% +$59.1K ﹤0.01% 1767
2025
Q3 		$501K Buy
+1,196
New +$402K ﹤0.01% 1763
2023
Q2 		– Sell
-900
Closed -$200K – 2031
2023
Q1 		$200K Sell
900
-44
-5% -$10.8K ﹤0.01% 1818
2022
Q4 		$262K Buy
944
+150
+19% +$37.9K ﹤0.01% 1541
2022
Q3 		$166K Buy
794
+465
+141% +$104K ﹤0.01% 1730
2022
Q2 		$76K Buy
329
+65
+25% +$13.2K ﹤0.01% 2092
2022
Q1 		$47K Buy
264
+10
+4% +$1.91K ﹤0.01% 2334
2021
Q4 		$54K Buy
254
+180
+243% +$35.3K ﹤0.01% 2188
2021
Q3 		$13K Sell
74
-825
-92% -$163K ﹤0.01% 2783
2021
Q2 		$161K Sell
899
-14
-2% -$2.67K ﹤0.01% 1599
2021
Q1 		$152K Buy
913
+72
+9% +$12K ﹤0.01% 1428
2020
Q4 		$127K Buy
841
+16
+2% +$2.1K ﹤0.01% 1353
2020
Q3 		$83K Sell
825
-300
-27% -$32.9K ﹤0.01% 1334
2020
Q2 		$136K Buy
1,125
+300
+36% +$33.8K ﹤0.01% 1066
2020
Q1 		$78K Hold
825
– – ﹤0.01% 1098
2019
Q4 		$73K Hold
825
– – ﹤0.01% 1054
2019
Q3 		$66K Buy
+825
New +$66.4K ﹤0.01% 899
2019
Q2 		– Sell
-251
Closed -$29K – 1989
2019
Q1 		$29K Buy
+251
New +$29.2K ﹤0.01% 1102

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Rockefeller Capital Management's UTHR Position: Q2 2026 in Review

Rockefeller Capital Management reduced its United Therapeutics (UTHR) stake by 3.6% in Q2 2026, selling an estimated $31.5K and leaving 1,506 shares worth $816K. The position accounts for ﹤0.01% of the portfolio, ranked #1832.

Rockefeller Capital Management first reported a position in UTHR in Q1 2019 and has held it in 20 quarters since. The position peaked at $926K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Rockefeller Capital Management held 1,506 shares of United Therapeutics worth $816K as of Q2 2026.
  • Rockefeller Capital Management sold 56 United Therapeutics shares in Q2 2026, an estimated $31.5K.
  • United Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1832 holding.
  • Rockefeller Capital Management first reported a position in United Therapeutics in Q1 2019 and has held it in 20 quarters since.
  • Rockefeller Capital Management's United Therapeutics position peaked at $926K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.